Humacyte, Inc. (NASDAQ:HUMA) Receives $11.71 Consensus Price Target from Brokerages
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating […]
Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating […]
